A high-protein neonatal formula induces a temporary reduction of adiposity and changes later adipocyte physiology.
The high-protein content of formula offered to low-birth weight babies is suspected to increase the risk of obesity later in life. This study assesses the immediate and subsequent effects of a protein intake in excess during suckling on hormonal and metabolic status and adipose tissue features in a porcine model of intrauterine growth restriction. Piglets were fed milk replacers formulated to provide an adequate (AP) or a high (HP) protein supply from day 2 to day 28. A subset of piglets was killed at day 28. After weaning, the remaining piglets had free access to the same solid high-fat diet until day 160. From day 2 to day 28, HP piglets had a greater daily weight gain (P < 0.05). Relative weight of perirenal adipose tissue (PAT), adipocyte mean diameters, activities of lipogenic enzymes in PAT and subcutaneous adipose tissue (SCAT), and leptinemia were lower (P < 0.05) in HP piglets than in AP piglets. Genes related to glucose utilization and lipid anabolism in PAT and SCAT were (P < 0.05) or tended (P < 0.1) to be downregulated in HP piglets. At day 160, adipocytes were enlarged, whereas lipogenic rates in adipocytes were reduced (P < 0.05) in SCAT of HP compared with AP pigs. Percent body fat, mRNA levels of genes controlling lipid metabolism, and plasma concentrations of hormones and metabolites were similar in HP and AP pigs. In conclusion, a HP neonatal formula induced a temporary reduction of adiposity and changed adipocyte physiology at peripubertal age.
INRA, UMR1079 SENAH, Domaine de la Prise, 35590 Saint-Gilles, France.
Ousseynou
O
Sarr
Florence
F
Gondret
Agnès
A
Jamin
Isabelle
I
Le Huërou-Luron
Isabelle
I
Louveau
D017667:Adipocytes / Q000166:cytology / Q000187:drug effects / Q000502:physiology*; D000273:Adipose Tissue / Q000033:anatomy & histology / Q000737:chemistry / Q000166:cytology / Q000187:drug effects / Q000378:metabolism; D050154:Adiposity / Q000187:drug effects / Q000502:physiology*; D000818:Animals; D000831:Animals, Newborn; D001823:Body Composition / Q000187:drug effects; D001835:Body Weight / Q000187:drug effects; D050260:Carbohydrate Metabolism / Q000187:drug effects / Q000235:genetics; D004247:DNA / Q000032:analysis; D004044:Dietary Proteins / Q000008:administration & dosage / Q000494:pharmacology*; D004435:Eating / Q000502:physiology; D004798:Enzymes / Q000235:genetics / Q000378:metabolism; D064429:Fatty Acid Synthases / Q000378:metabolism; D005260:Female; D005526:Food, Formulated; D015870:Gene Expression / Q000187:drug effects / Q000235:genetics; D005947:Glucose / Q000378:metabolism; D007328:Insulin / Q000494:pharmacology; D020738:Leptin / Q000097:blood; D050356:Lipid Metabolism / Q000187:drug effects / Q000235:genetics; D008055:Lipids / Q000097:blood; D008291:Malate Dehydrogenase / Q000378:metabolism; D008297:Male; D011506:Proteins / Q000032:analysis; D034421:Sus scrofa
D004044:Dietary Proteins; D004798:Enzymes; D007328:Insulin; D020738:Leptin; D008055:Lipids; D011506:Proteins; D004247:DNA; D008291:Malate Dehydrogenase; D064429:Fatty Acid Synthases; D005947:Glucose